|
Amounts in KSEK
|
2010*
Jan-Dec
|
2009*
Jan-Dec
|
2008*
Jan-Dec
|
2007*
Jan-Dec
|
2006*
Jan-Dec
|
| Net sales |
18,466 |
23,998 |
12,114 |
16,275 |
5,571 |
| Cost of goods & services sold** |
-4,024 |
-4,328 |
-4,194 |
-2,603 |
-616 |
| Gross profit |
14,442 |
19,670 |
7,920 |
13,672 |
4,955 |
| |
|
|
|
|
|
| Other income*** |
947 |
451 |
1,359 |
305 |
263 |
| Research and development costs** |
-14,637 |
-14,995 |
-15,502 |
-14,722 |
-43,177 |
| Selling costs |
-15,917 |
-17,049 |
-11,688 |
-9,134 |
-12,090 |
| Administrative costs |
-5,831 |
-5,729 |
-5,195 |
-5,343 |
-7,183 |
| Other costs*** |
-966 |
-861 |
-1,209 |
-408 |
-298 |
| Operating loss |
-21,962 |
-18,513 |
-24,315 |
-15,630 |
-57,530 |
| |
|
|
|
|
|
Interest income and other
financial income |
155 |
311 |
2,284 |
2,251 |
1,841 |
Interest expense and other
financial expense |
-558 |
-431 |
-602 |
-71 |
-330 |
| Net financial items |
-403 |
-120 |
1,682 |
2,180 |
1,511 |
| Loss after financial items |
-22,365 |
-18,633 |
-22,633 |
-13,450 |
-56,019 |
| |
|
|
|
|
|
| Taxes |
- |
- |
- |
- |
- |
| Loss for the year**** |
-22,365 |
-18,633 |
-22,633 |
-13,450 |
-56,019 |
| * |
Consolidated financial statements, incl. Artimplant USA, Inc. |
| ** |
Impairment of product development expenses brought forward are included in 2010 to the amount of KSEK 591 and 2006 to the amount of KSEK 17,118. |
| *** |
In 2008, Artimplant switched to reporting Other income och Other costs separately.
A recalculation has been made for previous years. |
| **** |
Concurs with the comprehensive income for the year
|
| Amounts in KSEK |
2010*
Dec.31 |
2009*
Dec.31 |
2008*
Dec. 31 |
2007*
Dec. 31 |
2006*
Dec. 31 |
| Total fixed assets |
1,797
|
3,501
|
6,680
|
10,006
|
10,214
|
| Total current assets |
45,107
|
26,997
|
40,309
|
59,606
|
72,863
|
| of which cash in hand and at the bank |
36,890
|
15,613
|
31,371
|
49,240
|
68,704
|
| Total assets |
46,904
|
30,498
|
46,989
|
69,612
|
83,077
|
| |
|
|
|
|
|
| Total equity |
34,402
|
23,853
|
41,965
|
64,249
|
77,614
|
| |
|
|
|
|
|
| Total provisions and non-current liabilities |
12
|
65
|
20
|
52
|
353
|
| Total current liabilities |
12,490
|
6,579
|
5,004
|
5,311
|
5,110
|
| Total equity and liabilities |
46,904
|
30,498
|
46,989
|
69,612
|
83,077
|
| * |
Consolidated financial statements, incl. Artimplant USA, Inc. |
| |
|
| |
|
| Amounts in KSEK |
2010*
Jan-Dec
|
2009*
Jan-Dec
|
2008*
Jan-Dec |
2007*
Jan-Dec |
2006*
Jan-Dec
|
| Cash flow from operations |
-15,098
|
-15,529
|
-17,357
|
-15,632
|
-33,190
|
| Cash flow from investment activities |
-265
|
-229
|
-590
|
-3,832
|
-2,292
|
| Cash flow from financial activities |
36,640
|
-
|
-
|
-
|
-
|
| Cash flow for the year |
21,277
|
-15,758
|
-17,948
|
-19,464
|
-35,482
|
Cash and cash equivalents as
of Jan 1 |
15,613
|
31,371
|
49,240
|
68,704
|
104,186
|
| Translation of foreign liquid assets |
-
|
-
|
79
|
-
|
-
|
| Cash and cash equivalents as of Dec 31 |
36,890
|
15,613
|
31,371
|
49,240
|
68,704
|
| * |
Consolidated financial statements, incl. Artimplant USA, Inc. |
| |
|
| |
|
|
